Growth Metrics

Mannkind (MNKD) Tax Provisions (2012 - 2026)

Mannkind (MNKD) reported Tax Provisions of $253000.0 for Q1 2026, down 44.88% year-over-year from $459000.0 in Q1 2025, and up 844.12% on a QoQ basis from -$34000.0 in Q4 2025.

Mannkind (MNKD) has 8 years of Tax Provisions data on file, last reported at $253000.0 in Q1 2026.

  • Quarterly Tax Provisions fell 44.88% year-over-year to $253000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $291000.0 (down 90.64% YoY) and the FY2025 annual result came in at $493000.0, down 83.17% from the prior year.
  • Tax Provisions rose to $253000.0 in Q1 2026 per MNKD's latest filing, from -$34000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.6 million in Q4 2023 and bottomed at -$200000.0 in Q3 2025.
  • The 4-year median for Tax Provisions is $286000.0 (2024), against an average of $521900.0.
  • Peak annual rise in Tax Provisions reached 73.86% in 2025, while the deepest fall reached 115.15% in 2025.
  • Tracing MNKD's Tax Provisions over 4 years: stood at $1.6 million in 2023, then plunged by 33.76% to $1.0 million in 2024, then slumped by 103.3% to -$34000.0 in 2025, then surged by 844.12% to $253000.0 in 2026.
  • Per Business Quant, the three latest MNKD Tax Provisions figures stand at $253000.0 (Q1 2026), -$34000.0 (Q4 2025), and -$200000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 253,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 253,000.00
Dec 31, 2025 -34,000.00
Sep 30, 2025 -200,000.00
Jun 30, 2025 272,000.00
Mar 31, 2025 459,000.00
Dec 31, 2024 1.03 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 300,000.00
Mar 31, 2024 264,000.00
Dec 31, 2023 1.56 Mn
Sep 30, 2020 -218,000.00
Jun 30, 2018 240,000.00
Dec 31, 2017 51,000.00
Sep 30, 2012 -408,000.00